Display options
Share it on

World J Nephrol. 2014 Aug 06;3(3):107-13. doi: 10.5527/wjn.v3.i3.107.

Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients.

World journal of nephrology

Enver Khan, Mary Killackey, Damodar Kumbala, Heather LaGuardia, Yong-Jun Liu, Huai-Zhen Qin, Brent Alper, Anil Paramesh, Joseph Buell, Rubin Zhang

Affiliations

  1. Enver Khan, Mary Killackey, Damodar Kumbala, Heather LaGuardia, Yong-Jun Liu, Huai-Zhen Qin, Brent Alper, Anil Paramesh, Joseph Buell, Rubin Zhang, Section of Nephrology, Department of Medicine, New Orleans, LA 70112, United States.

PMID: 25332902 PMCID: PMC4202487 DOI: 10.5527/wjn.v3.i3.107

Abstract

AIM: To study the long-term outcome of ketoconazole and tacrolimus combination in kidney transplant recipients.

METHODS: From 2006 to 2010, ketoconazole was given in 199 patients and was continued for at least 1 year or until graft failure (Group 1), while 149 patients did not receive any ketoconazole (Group 2). A combination of tacrolimus, mycophenolate and steroid was used as maintenance therapy. High risk patients received basiliximab induction.

RESULTS: Basic demographic data was similar between the 2 groups. The 5-year cumulative incidence of biopsy-confirmed and clinically-treated acute rejection was significantly higher in Group 1 than in Group 2 (34% vs 18%, P = 0.01). The 5-year Kaplan-Meier estimated graft survival (74.3% vs 76.4%, P = 0.58) and patient survival (87.8% vs 87.5%, P = 0.93) were not different between the 2 groups. Multivariable analyses identified ketoconazole usage as an independent risk of acute rejection (HR = 2.33, 95%CI: 1.33-4.07; P = 0.003) while tacrolimus dose in the 2(nd) month was protective (HR = 0.89, 95%CI: 0.75-0.96; P = 0.041).

CONCLUSION: Co-administration of ketoconazole and tacrolimus is associated with significantly higher incidence of acute rejection in kidney transplant recipients.

Keywords: Cytochrome P450; Kidney transplant; Pharmacokinetics; Rejection; Survival; Tacrolimus Ketoconazole

References

  1. Nephrol Dial Transplant. 2006 Jun;21(6):1689-96 - PubMed
  2. J La State Med Soc. 2012 Jul-Aug;164(4):191-3 - PubMed
  3. J Am Soc Nephrol. 2014 Feb;25(2):407-19 - PubMed
  4. Transplantation. 2013 Jan 27;95(2):397-402 - PubMed
  5. Nephrol Dial Transplant. 2004 Jun;19(6):1613-7 - PubMed
  6. Am J Transplant. 2010 Oct;10(10):2263-9 - PubMed
  7. Kidney Int. 2005 Jun;67(6):2440-7 - PubMed
  8. World J Transplant. 2012 Apr 24;2(2):19-26 - PubMed
  9. Clin Transplant. 2013 May-Jun;27(3):E272-81 - PubMed
  10. Drug Metabol Drug Interact. 2012;27(3):151-5 - PubMed
  11. Transplantation. 2014 Mar 27;97(6):702-7 - PubMed
  12. Am J Transplant. 2007 Dec;7(12):2816-20 - PubMed
  13. Pharmacogenet Genomics. 2011 Nov;21(11):713-20 - PubMed
  14. N Engl J Med. 2010 Nov 18;363(21):2004-14 - PubMed
  15. Liver Transpl. 2012 Jun;18(6):716-26 - PubMed
  16. Am J Transplant. 2004 Sep;4(9):1514-22 - PubMed
  17. Am J Kidney Dis. 2001 Mar;37(3):510-7 - PubMed
  18. Am J Nephrol. 2006;26(3):293-8 - PubMed
  19. Transplant Proc. 2002 Aug;34(5):1540-1 - PubMed
  20. Transplantation. 2004 May 15;77(9):1371-6 - PubMed

Publication Types